Loading...
NPI 1619913449 · Sacramento, CA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Unilab Corporation is a clinical medical laboratory provider located in Sacramento, California. This profile covers 518 Medicare and 551 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Unilab Corporation |
| Address | 3714 Northgate Blvd |
| City | Sacramento |
| State | CA |
| ZIP | 95834 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 21, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $141.3M |
| Medicare | $47.1M |
UNILAB CORPORATION is a long‑standing clinical laboratory NPI enumerated on 2006-06-21 (~20 years ago), indicating roughly two decades of operation in the Medicare/Medicaid billing environment and sufficient tenure to develop large payer relationships and testing workflows.
Medicaid is the larger payer relationship by scale for this entity: reported lifetime Medicaid revenue is $141.3M versus total Medicare revenue of $47.1M, signaling a materially larger Medicaid footprint and potential reliance on state program volume.
Revenue concentration within each payer is meaningfully focused: the top 3 Medicare codes account for 35.6% of this provider's total Medicare revenue, while the top 3 Medicaid codes account for 28.4% of its total Medicaid revenue, indicating a multi‑code concentration rather than highly diffuse revenue sources.
The Medicare top revenue drivers (36415, 80053, 80061) reflect very high volumes of phlebotomy and routine chemistry testing: 36415 ($4.3M, ranks #10 of 86467 nationally, 100th percentile; extreme outlier), 80053 ($4.2M, ranks #12 of 26416 nationally, 100th percentile; extreme outlier), and 80061 ($3.7M, ranks #12 of 21671 nationally, 100th percentile; extreme outlier). Together these suggest a high‑throughput clinical reference lab model with heavy outpatient specimen collection and processing.
Medicaid top codes (87591, 87491, U0003) show a strong public‑health and infectious disease testing emphasis: 87591 and 87491 each generated $11.2M (each 11.0% of Medicaid revenue and both rank #3 in‑state, 100th percentile; extreme outliers) and U0003 contributed $6.6M (6.4% of Medicaid revenue, rank #30 in‑state, 96th percentile). This mix points to large volumes of GC/CT screening and high‑throughput COVID molecular testing under Medicaid contracts or wide clinical adoption.
Across both payers the provider posts numerous extreme outlier ranks for common lab assays, supporting a characterization as a dominant high‑volume testing center: Medicare ranks include multiple 100th percentile placements (e.g., 84443, 82306, 85025) and Medicaid ranks include repeated #2/#3 positions statewide for high‑volume infectious and screening panels (e.g., 86480 rank #2 in‑state; 80081 rank #2 in‑state). These rank patterns are consistent with a major reference lab or centralized laboratory services operation serving a wide network of clinics.
Drug and toxicology testing are also material to the business mix: Medicare shows G0480 at $1.8M (5.3% of Medicare revenue, rank #4 nationally, 100th percentile; extreme outlier) and 80307 at $1.1M (3.2% of Medicare revenue, rank #9 nationally, 100th percentile; extreme outlier); Medicaid likewise lists 80307 at $4.6M (4.5% of Medicaid revenue, rank #4 in‑state, 100th percentile). The presence of high‑rank definitive and presumptive drug testing suggests dedicated toxicology capacity and potentially specialized workflows or panels.
While the portfolio includes many routine clinical assays (CMP, BMP, A1C, CBC) the Medicaid list emphasizes population screening and public health diagnostics—HIV (87389 $3.9M), hepatitis C (86803 $1.9M), syphilis screening (86592 $1.6M), HPV and BV testing (87624 $2.9M, 81513 $2.5M)—indicating the provider serves a broad set of preventive and diagnostic needs for state Medicaid populations. This combination of routine panels and infectious disease screening supports a dual role as both a high‑volume clinical lab and a public‑health testing partner.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
518 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 539,250 | $10 | $4.3M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 415,170 | $10 | $4.2M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 283,000 | $10 | $3.7M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 206,390 | $20 | $3.3M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 94,480 | $30 | $2.7M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 320,460 | $10 | $2.6M |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 191,680 | $10 | $1.9M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 16,130 | $110 | $1.8M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 17,970 | $60 | $1.1M |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 65,820 | $20 | $987.3K |
Showing 1–10 of 518
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 518 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
518 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81479 | 10 | 20 | 650 | $2,290 | $16.6M |
| G0482 | 14 | 30 | 70 | $190 | $555.9K |
| 87999 | 2 | 10 | 1,450 | $290 | $436.6K |
| G0483 | 43 | 70 | 360 | $240 | $427.9K |
| 87798 | 84 | 110 | 1,340 | $30 | $338.2K |
| U0003 | 29 | 130 | 730 | $70 | $246.4K |
| G0481 | 9 | 50 | 250 | $150 | $131.2K |
| G0480 | 1 | 50 | 70 | $110 | $119.4K |
| 86235 | 7 | 60 | 1,220 | $20 | $75.7K |
| U0005 | 35 | 150 | 780 | $20 | $75.1K |
Showing 1–10 of 518
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
551 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 933,370 | $10 | $11.2M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 931,730 | $10 | $11.2M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 88,660 | $70 | $6.6M |
| 86480 | The lab analyst performs a test to evaluate a cell mediated immunity gamma interferon antigen response to certain tuberculosis, or TB, antibodies. | 330,370 | $20 | $6.3M |
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 46,030 | $130 | $6M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 1,745,770 | $1 | $5.2M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 1,177,030 | $1 | $4.7M |
| 80081 | The lab analyst performs an obstetric panel; this panel must include tests for a complete blood count with differential, a hepatitis B surface antigen test, a single–result test for HIV–1 antigens… | 128,600 | $40 | $4.6M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 303,500 | $20 | $4.6M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 2,000,270 | $1 | $4M |
Showing 1–10 of 551
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
551 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 10 | 30 | 300 | $260 | $18M |
| 81162 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the BRCA1, DNA repair–associated gene, also called BRCA1; and BRCA2, DNA repair–associated gene, also called… | 9 | 10 | 440 | $500 | $5.3M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 7 | 60 | 370 | $80 | $4.1M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 27 | 100 | 520 | $120 | $2.4M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 20 | 70 | 650 | $70 | $1.6M |
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 7 | 110 | 190 | $140 | $1.6M |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 28 | 50 | 500 | $160 | $1.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 30 | 750 | 950 | $50 | $890K |
| 81257 | The lab analyst performs the technical lab test to detect the presence of specific changes and possible deleted nucleotides in the alpha globin 1 and alpha globin 2 genes, also known as HBA1/HBA2,… | 6 | 10 | 1,960 | $20 | $830.3K |
| 81329 | The lab analyst performs the technical lab test to detect deletions in the survival of motor neuron 1 (SMN1), telomeric, gene and may also analyze the survival of motor neuron 2 (SMN2), centromeric,… | 8 | 60 | 400 | $40 | $748.5K |
Showing 1–10 of 551
Other providers in the same ZIP code as Unilab Corporation, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Peach Tree Healthcare | CA | Federally Qualified Health Center (FQHC) | $0 | $44.9M |
| Mark David Levine M.d. Professional Corporation | CA | Psychiatry Physician | $0 | $26M |
| Altamedix Corporation | CA | Adult Day Care Clinic/Center | $0 | $22.8M |
| Pmdlab, LLC | CA | Clinical Medical Laboratory | $1.2M | $1.2M |
| Unilab Corporation | CA | Clinical Medical Laboratory | $60.8K | $11.5K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.